Harmony Biosciences Holdings Inc (HRMY)
30.11
-1.17
(-3.74%)
USD |
NASDAQ |
May 10, 16:00
30.11
0.00 (0.00%)
After-Hours: 18:13
Harmony Biosciences Holdings Shareholders Equity (Quarterly): 515.39M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 515.39M |
| December 31, 2023 | 466.99M |
| September 30, 2023 | 481.33M |
| June 30, 2023 | 485.17M |
| March 31, 2023 | 443.04M |
| December 31, 2022 | 402.84M |
| September 30, 2022 | 343.88M |
| June 30, 2022 | 246.53M |
| March 31, 2022 | 214.50M |
| Date | Value |
|---|---|
| December 31, 2021 | 186.51M |
| September 30, 2021 | 152.02M |
| June 30, 2021 | 126.55M |
| March 31, 2021 | 107.88M |
| December 31, 2020 | 97.18M |
| September 30, 2020 | 94.55M |
| June 30, 2020 | -49.35M |
| March 31, 2020 | -49.69M |
| December 31, 2019 | -11.58M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-49.69M
Minimum
Mar 2020
515.39M
Maximum
Mar 2024
236.32M
Average
200.50M
Median
Shareholders Equity (Quarterly) Benchmarks
| Amylyx Pharmaceuticals Inc | 433.43M |
| Exelixis Inc | 2.128B |
| Insmed Inc | -331.92M |
| Ultragenyx Pharmaceutical Inc | 140.26M |
| Immunic Inc | 28.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 846.98M |
| Total Liabilities (Quarterly) | 331.59M |
| Debt to Equity Ratio | 0.3686 |
| Current Ratio | 3.108 |
| Net Debt Paydown Yield | 0.02% |